ConductScience.org, home

Paper40938464

The functions and regulation of transcription factor YBX1 in cancers.

Qiu A and 4 others. Mol Biol Rep, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The functions and regulation of transcription factor YBX1 in cancers. Papers, record 40938464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40938464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The functions and regulation of transcription factor YBX1 in cancers.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-11-05
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qiu AAixin
2Zhang YYue
3Dong YYihan
4Yue DDan
5Yu YYang

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Y-Box-Binding Protein 1Major topic
NeoplasmsMajor topic
Humans
Gene Expression Regulation, Neoplastic
Animals
Cell Nucleus
RNA Splicing
DNA Repair

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022LCYJZD02the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical UniversityPubMed
2022LCYJZD02the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical UniversityPubMed
2022LCYJZD02the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical UniversityPubMed
2024-MSLH-108Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology PlanPubMed
2024-MSLH-108Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology PlanPubMed
2024-MSLH-108Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology PlanPubMed

Source PubMed

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1313589695-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.Nat Cell Biol2019https://conductscience.org/library/papers/31358969PubMed
236805592PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1.Cell Death Discov2023https://conductscience.org/library/papers/36805592PubMed
338847599LNCHC directly binds and regulates YBX1 stability to ameliorate metabolic dysfunction-associated steatotic liver disease progression.Liver Int2024https://conductscience.org/library/papers/38847599PubMed
4362113535-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis.Front Immunol2022https://conductscience.org/library/papers/36211353PubMed
535260638YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma.Sci Rep2022https://conductscience.org/library/papers/35260638PubMed
69759494The ubiquitin system.Annu Rev Biochem1998https://conductscience.org/library/papers/9759494PubMed
735273154SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1.Oncogenesis2022https://conductscience.org/library/papers/35273154PubMed
832561752YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC.Cell Death Dis2020https://conductscience.org/library/papers/32561752PubMed
924378923Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.Int J Oncol2014https://conductscience.org/library/papers/24378923PubMed
1035292781Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway.Nat Cell Biol2022https://conductscience.org/library/papers/35292781PubMed
1139216548YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.Cancer Lett2024https://conductscience.org/library/papers/39216548PubMed
1218851979RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1.J Mol Biol2008https://conductscience.org/library/papers/18851979PubMed
1335501989Role of YB-1 Protein in Inflammation.Biochemistry (Mosc)2022https://conductscience.org/library/papers/35501989PubMed
1430258867Role of post-translational modification of the Y box binding protein 1 in human cancers.Genes Dis2015https://conductscience.org/library/papers/30258867PubMed
1534991621CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.J Transl Med2022https://conductscience.org/library/papers/34991621PubMed
1639400789YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1.Med Oncol2024https://conductscience.org/library/papers/39400789PubMed
1731178151Nasopharyngeal carcinoma.Lancet2019https://conductscience.org/library/papers/31178151PubMed
1836600625Circ_0002762 Regulates Oncoprotein YBX1 in Cervical Cancer via mir-375 to Regulate the Malignancy of Cancer Cells.Protein Pept Lett2023https://conductscience.org/library/papers/36600625PubMed
1931906126Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus.Cells2019https://conductscience.org/library/papers/31906126PubMed
2022406545EMT as the ultimate survival mechanism of cancer cells.Semin Cancer Biol2012https://conductscience.org/library/papers/22406545PubMed

See all 91 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42698848YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42698848PubMed
42246500Human lncRNA, hLinfRNA7 (IDO1-AS) Regulates Cytokine Expression, Tryptophan Catabolism, and Inflammatory Response in Macrophage.Mol Cell Biol2026https://conductscience.org/library/papers/42246500PubMed
41994112YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target.Res Sq2026https://conductscience.org/library/papers/41994112PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
YBX14904PubTator's text mininghttps://conductscience.org/library/genes/4904

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40938464

GET https://conductscience.org/api/papers/v1/40938464/references?page=2